Cardiovascular Diabetology

FEBRUARY 19, 2024

Early since the onset of the COVID-19 pandemic, the medical and scientific community were aware of extra respiratory actions of SARS-CoV-2 infection. Endothelitis, hypercoagulation, and hypofibrinolysis were i.

COVID-19 111

COVID-19 Thrombosis Diabetes 111

American Heart News - Stroke News

JANUARY 29, 2024

DALLAS, January 29, 2024 — A new scientific statement from the American Heart Association emphasizes the need to increase patients’ and physicians’ awareness of cerebral venous thrombosis (CVT) to improve the recognition of this condition and initiate.

Risk Factors 132

Risk Factors Thrombosis Strokes Stroke 132

Frontiers in Cardiovascular Medicine

FEBRUARY 21, 2024

Acute extensive portal venous system thrombosis (PVST) can cause lethal complications. Herein, we have for the first time reported the use of anticoagulation combined with systemic thrombolysis by tenecteplase in a male patient with a diagnosis of acute extensive PVST but without liver cirrhosis.

Thrombosis 59

Thrombosis Thrombolysis 59

Journal of Cardiothoracic Surgery

JUNE 25, 2024

Intra-cardiac thrombosis is a potentially devastating complication of extracorporeal membrane oxygenation (ECMO) mechanical circulatory support. We present here a patient who suffered complete thrombosis of a.

Thrombosis 52

Thrombosis Bicuspid/Mitral Outcomes 52

Frontiers in Cardiovascular Medicine

MARCH 19, 2024

Background Deep vein thrombosis (DVT) is associated with aberrant gene expression that is a common peripheral vascular disease. Methods In order to explore the relationship between microRNAs (miRNAs) and FOXP3, mRNA and microRNA microarray analysis were performed.

Thrombosis 59

Thrombosis Ultrasound 59

ECG Cases

APRIL 11, 2023

How do the presentations of cerebral venous thrombosis (CVT) and idiopathic intracranial hypertension (IIH) compare and contrast? The post Ep181 Cerebral Venous Thrombosis, Idiopathic Intracranial Hypertension, Giant Cell Arteritis and Peripartum Headaches appeared first on Emergency Medicine Cases. and many more.

Thrombosis 52

Thrombosis Hypertension 52

Stroke Journal

FEBRUARY 1, 2024

Introduction:Deep medullary vein(DMV) thrombosis is a rare cause of neurological damage noted in both term and preterm infants. Although their incidence in children is not know, DMV thrombosis can occur isolated or in association with cerebral sinovenous thrombosis (CSVT). In none of these cases treatment options were described.

Thrombosis 40

Thrombosis Hemorrhage Stroke Strokes 40

Frontiers in Cardiovascular Medicine

JULY 5, 2024

Left-sided bioprosthesis valve thrombosis (LSBVT) is a challenging complication necessitating invasive interventions. In this study, we introduce a novel, minimally invasive approach.

Thrombosis 52

Thrombosis Embolism 52

ECG Cases

JANUARY 26, 2021

In this month's EM Quick Hits podcast: Justin Morgenstern on which patients to consider cerebral venous thrombosis in, Maria Ivankovic on diphenhydramine alternatives, Brit Long on abdominal compartment syndrome, Sarah Reid on neonatal "constipation" - when to worry, and Anand Swaminathan on intubating the patient with metabolic acidosis.

Thrombosis 52

Thrombosis Pediatrics 52

Know Your Heart

FEBRUARY 20, 2019

Deep Vein Thrombosis What is deep vein thrombosis? Deep vein thrombosis (DVT) occurs when a blood clot forms in a deep-lying vein, usually in the legs. Such a clot is dangerous because the clot may break loose, travel through your bloodstream, and block arteries in your lungs, causing permanent damage or death.

Thrombosis 40

Thrombosis Blood Clot Heart Disease 40

Science Daily - Heart Disease

OCTOBER 16, 2024

New research has shown that over the long-term, standing more compared with sitting does not improve cardiovascular health (coronary heart disease, stroke and heart failure), and could increase the risk of circulatory issues related to standing, such as varicose veins and deep vein thrombosis.

Research 106

Research Cardiovascular Disease Thrombosis Heart Failure 106

Frontiers in Cardiovascular Medicine

JULY 1, 2024

Notably, acute massive pulmonary embolism (PE) with bilateral atrial thrombosis is an exceptional occurrence in CAPS. Acute massive PE combined with bilateral atrial thrombosis has an even higher mortality rate. Acute pulmonary embolism (PE) is a common cardiovascular disease that progresses rapidly and has a high mortality rate.

Thrombosis 52

Thrombosis Embolism Pulmonary Laboratory 52

Cardiology Update

FEBRUARY 11, 2024

Bioprosthetic valve dysfunction (BVD) was categorized into structural valve deterioration (SVD), non-structural valve dysfunction (NSVD), clinical valve thrombosis, or endocarditis. No cases of clinical valve thrombosis were reported. Severe SVD was defined by specific criteria.

Aortic valve 124

Aortic valve Aortic Outcomes Thrombosis 124

Dr. Anish Koka

DECEMBER 13, 2023

of patients in the WATCHMAN arm had evidence of a definite or probably Device Related Thrombosis (DRT). Reflecting contemporary practice, most patients at 45 days after implant were either on single antiplatelet or dual antiplatelet therapy. At one year, 10% of patients in both arms were dead, and 9.9%

Thrombosis 59

Thrombosis Atrial Fibrillation Strokes Stroke 59

DAIC

SEPTEMBER 10, 2024

Angiolillo, MD, PhD, FACC, FESC, FSCAI, Professor of Medicine, Chief, Division of Cardiology, Director, Thrombosis Research Center, University of Florida, College of Medicine-Jacksonville. The Prolocor pFCG test will be an important asset as we tailor antiplatelet therapies to balance thrombotic and bleeding risk" said Dominick J.

Thrombosis 52

Thrombosis Coronary Artery Disease Innovation Stents 52

American College of Cardiology

JANUARY 9, 2024

Active cancer is a strong risk factor for venous thromboembolism (VTE) events and recurrent events following discontinuation of anticoagulation therapy, and cancer patients are also at a heightened risk for bleeding complications related to anticoagulation treatment.

Cancer 64

Cancer Thrombosis Risk Factors Article 64

Circulation

NOVEMBER 11, 2024

Introduction:Subclinical leaflet thrombosis is an increasingly recognized complication in patients undergoing transcatheter aortic valve replacement (TAVR). The optimized TAV design could reduce the risk of subclinical leaflet thrombosis in patients undergoing TAVR.

Aortic valve 40

Aortic valve Thrombosis Aortic TAVR 40

Frontiers in Cardiovascular Medicine

DECEMBER 17, 2023

Background D-Dimer testing is a diagnostic tool for exclusion of deep vein thrombosis (DVT) and pulmonary embolism (PE). This study evaluated the diagnostic performance of the Tina-quant® D-Dimer Gen.2

Thrombosis 64

Thrombosis Embolism Pulmonary Laboratory 64

Med Page Today

OCTOBER 15, 2024

Arteriosclerosis, Thrombosis, and Vascular Biology. (MedPage Today) -- Severe COVID-19 infection was associated with major cardiac events as much as -- and in some cases more than -- having a history of heart disease, U.K. Biobank data showed.

COVID-19 84

COVID-19 Thrombosis Heart Disease 84

Stroke Journal

FEBRUARY 1, 2024

Background:Coronavirus disease 2019 (COVID-19) increases the risk of cerebral venous sinus thrombosis (CVST), and previous reports derived from small case series reported a high mortality in these patients, up to 40%. Stroke, Volume 55, Issue Suppl_1 , Page ATP180-ATP180, February 1, 2024.

COVID-19 40

COVID-19 Thrombosis Outcomes Hospital 40

Circulation

SEPTEMBER 15, 2024

Circulation, Volume 150, Issue 12 , Page 905-907, September 17, 2024.

Thrombosis 45

Thrombosis Circulation 45

The New England Journal of Medicine

NOVEMBER 20, 2024

A man with monoclonal gammopathy of undetermined significance and thrombosis was found to have a previously undetected pathogenic monoclonal antibody that activated platelets in a PF4-dependent manner.

Thrombosis 75

Thrombosis 75

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionCerebral venous sinus thrombosis (CVST) is a rare form of stroke that usually affects young females especially during pregnancy and the postpartum period. The symptoms of cerebral venous sinus thrombosis can vary depending on the location and extent of the clot.

Thrombosis 40

Thrombosis Outcomes Cancer Risk Factors 40

Heart BMJ

DECEMBER 20, 2023

Objectives The effect of subclinical leaflet thrombosis, characterised by hypoattenuated leaflet thickening (HALT), on the valve haemodynamic function and durability of the bioprosthetic valve, is not yet determined.

Aortic valve 40

Aortic valve Thrombosis Aortic TAVR 40

Stroke Journal

FEBRUARY 1, 2024

Introduction:Seizures are a common initial manifestation of cerebral venous thrombosis (CVT).

Thrombosis 40

Thrombosis Hemorrhage Risk Factors Outcomes 40

American College of Cardiology

NOVEMBER 5, 2024

The following are key points to remember from a state-of-the art review on antithrombotic therapy in patients with high bleeding risk (HBR) noncardiac percutaneous interventions from the Working Group of Thrombosis of the Italian Society of Cardiology.

Thrombosis 74

Thrombosis Article 74

Medical Xpress - Cardiology

AUGUST 19, 2024

Therefore, preventing and treating thrombosis is crucial to avoid severe complications. An unhealthy lifestyle, diseases or injuries, genetic predisposition, and increased coagulation tendency can promote the formation of thrombi in blood vessels.

Genetic predisposition 76

Genetic predisposition Thrombosis 76

American College of Cardiology

OCTOBER 15, 2024

The following are key points to remember from a state-of-the-art review on antithrombotic therapy in patients at high bleeding risk (HBR) from the Working Group of Thrombosis of the Italian Society of Cardiology.

Thrombosis 73

Thrombosis Article 73

Frontiers in Cardiovascular Medicine

FEBRUARY 1, 2024

In addition, with the prevalence of COVID-19 infection, more and more studies report that COVID-19 infection may lead to arteriovenous thrombosis, which could cause lower limb ischemia. Clinically, they are mainly seen in the form of popliteal artery entrapment syndrome (PAES).

COVID-19 64

COVID-19 Ischemia Thrombosis 64

Frontiers in Cardiovascular Medicine

DECEMBER 18, 2024

For example, proteins involved in inflammation, thrombosis, and cardiac remodeling have been identified as potential therapeutic targets. Analysis of the EV proteome has been instrumental in identifying key proteins that can be targeted or modulated within these engineered vesicles.

Cardiovascular Disease 89

Cardiovascular Disease Thrombosis Physiology Research 89

Stroke Journal

FEBRUARY 1, 2024

Background:Information on long-term care utilization patterns following the acute care period of cerebral venous thrombosis (CVT) is limited. Stroke, Volume 55, Issue Suppl_1 , Page AWMP59-AWMP59, February 1, 2024.

Thrombosis 40

Thrombosis Cancer Strokes Stroke 40

Stroke Journal

FEBRUARY 1, 2024

Background:Cerebral venous thrombosis (CVT) is associated with significant risk of death and disability. Stroke, Volume 55, Issue Suppl_1 , Page AWP260-AWP260, February 1, 2024.

COVID-19 40

COVID-19 Thrombosis Inpatient Hospital 40

Stroke Journal

FEBRUARY 1, 2024

Our findings highlight the potential of conservative care for ruptured spinal artery aneurysms, with spontaneous thrombosis demonstrated on short-term follow-up angiograms. Crucially, all five patients achieved resolution and aneurysm occlusion on repeat angiograms.

Aneurysm 40

Aneurysm Thrombosis Hypertension Stroke 40

Frontiers in Cardiovascular Medicine

JULY 22, 2024

These included three cases of intraoperative thrombosis, three instances of pericardial effusion or tamponade, one case of device-related thrombosis, one peri-device leak, one systemic embolism, one bleeding episode, and one additional device-related complication.

Ablation 59

Ablation Thrombosis Embolism Atrial Fibrillation 59

Stroke Journal

OCTOBER 1, 2024

Stroke, Ahead of Print.

Thrombosis 40

Thrombosis Strokes Stroke 40

Stroke Journal

FEBRUARY 1, 2024

Introduction:Exposure to high altitude environment is a risk factor of cerebral venous thrombosis (CVT) probably due to the hypercoagulability. Stroke, Volume 55, Issue Suppl_1 , Page ATP267-ATP267, February 1, 2024.

Thrombosis 40

Thrombosis Risk Factors Hospital Hemorrhage 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionCerebral sinus venous thrombosis (CSVT) has traditionally been treated medically with systemic anticoagulation. Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. Recent advances in endovascular therapy (EVT) may represent an alternative treatment to medical therapy for CSVT.

Thrombosis 40

Thrombosis Outcomes Stroke Strokes 40